前列地尔注射液治疗后循环缺血性眩晕临床观察  

Clinical observation of Alprostadil Injection in the treatment of patients with vertigo caused by posterior circulation ischemia

作　　者：尹世敏[1] 李秋俐[1] 陈红[1] 张以善[1] 王佳楠[1] 冯枫[1] 王磊[1] 

机构地区：[1]第二炮兵总医院神经内科,北京100088

出　　处：《中国当代医药》2012年第17期51-52,共2页China Modern Medicine

摘　　要：目的观察前列地尔注射液添加治疗对后循环缺血性眩晕的临床疗效。方法将后循环缺血性眩晕患者84例随机分为两组,对照组42例给予天麻素注射液静脉滴注,治疗组42例在此基础上加用前列地尔注射液静滴,10d后评估疗效。结果治疗组总有效率为90.5%,对照组总有效率为73.8%,治疗组疗效优于对照组,两组比较,差异有统计学意义(χ2=3.977,P<0.05)。结论前列地尔注射液添加治疗后循环缺血性眩晕疗效较好,无明显不良反应。Objective To observe the curative effect of Alprostadil Injection in the treatment of vertigo caused by posterior circulation ischemia （PCI）. Methods Eighty four patients with vertigo caused by PCI were randomly divided into two groups, the control group （n = 42） was treated with Gastrodin Injection intravenous drip, and the treatment group （n = 42） was treated with Alprostadil Injection intravenous drip, which based on the treatment of control group. The curative effect was judged after 10 days. Results The total effective rate of the treatment group was 90.5%, and that of control group was 73.8%. The effective rate of treatment group was higher than that of the control group, there was significant difference be- tween the two groups （x2=3.977, P 〈 0.05）. Conclusion The Alprostadil injection in the treatment of vertigo caused by PCI can alleviate the symptoms, and it is an effective and safe medicine.

关 键 词：后循环缺血 眩晕 前列地尔注射液 天麻素注射液 

分 类 号：R743[医药卫生—神经病学与精神病学]